Streetbeat News

Revenues

GH

Guardant Health announced that data from its ECLIPSE study, demonstrating the efficacy of its Shield blood-based test for colorectal cancer screening, will be published in The New England Journal of Medicine.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 9:01 pm

BOKF

BOK Financial (NASDAQ:BOKF) has been analyzed by 4 analysts, all maintaining a neutral stance with updated price targets reflecting a slight optimism. The average 12-month price target is now $94.25, up from $91.75. Despite this, BOK Financial faces challenges with a -14.89% revenue decline, below-average market capitalization, and lagging net margin, ROE, and ROA compared to industry benchmarks. Analysts from Citigroup, Stephens & Co., RBC Capital, and Keefe, Bruyette & Woods have all raised their price targets, indicating a cautiously optimistic outlook.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 9:00 pm

OZK

Bank OZK (NASDAQ:OZK) has received mixed analyst ratings over the past quarter, with a recent shift towards a more bullish outlook. The average 12-month price target for OZK has been raised to $50.00, indicating a potential upside. Analysts from Citigroup, Wells Fargo, Raymond James, and Truist Securities have adjusted their ratings and price targets, reflecting their latest views on the bank's performance. Bank OZK has shown strong financial performance, with notable revenue growth, high net margin, and exceptional ROE and ROA, outperforming industry averages.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 9:00 pm

RDFN

Z

Realtor.com's analysis of the housing market reveals the hottest and coldest metro areas based on supply and demand scores. The coldest markets are mostly in the south, with Houma-Thibodaux, Louisiana being the coldest. The hottest market is Manchester-Nashua, New Hampshire. Companies like Redfin Corp (RDFN) and Zillow Group (Z) also track real estate trends. Mortgage rates have slightly decreased from their 24-year high, influencing demand for new homes.

Portfolio Pulse from Aaron Bry

March 13, 2024 | 8:59 pm

ARTNA

Artesian Resources (NASDAQ:ARTNA) reported Q4 earnings of $0.34 per share, surpassing the $0.31 estimate, marking a 41.67% increase from last year. However, their sales of $24.55M fell short of the $26.00M estimate, a 2.28% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 8:54 pm

PTMN

Portman Ridge Finance (PTMN) reported Q4 2023 earnings of $1.19 per share, surpassing the $0.79 estimate by 50.63%. However, their sales of $17.800M fell short of the $19.043M estimate by 6.53%, marking a 4.30% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 8:38 pm

ANIK

Anika Therapeutics projects FY24 revenue to be between $168M-$173M, below the estimated $179.42M. The company aims for accelerated profitability growth, with a focus on high-growth products. Revenue growth is expected across different product families, with OA Pain Management growing 0% to 2%, Joint Preservation and Restoration by 6% to 10%, and a decline in Non-Orthopedic by 14% to 19%. Adjusted EBITDA is anticipated to be $25M-$30M, a significant increase, reflecting cost savings and new product ramp-ups.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 8:35 pm

GRWG

GrowGeneration projects its FY24 revenue to be between $205M-$215M, which is below the estimated $219.016M.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 8:33 pm

SGC

Superior Group Of Companies (SGC) forecasts its full-year 2024 sales to be between $558M-$568M, closely aligning with the estimated $563.32M. However, its projected EPS of $0.61-$0.68 falls short of the estimated $0.71.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 8:29 pm

KRMD

KORU Medical Systems projects its FY24 revenue to be in the range of $31.2M-$32.2M, which is slightly below the estimated $32.260M.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 8:28 pm